Uric acid, heart failure survival, and the impact of xanthine oxidase inhibition (Q38010248)

26 August 2017

Uric acid, heart failure survival, and the impact of xanthine oxidase inhibition (English)

1 reference

26 August 2017

0 references

Arash Harzand

1

1 reference

PubMed ID

22587748

26 August 2017

Leonardo Tamariz

series ordinal

2

1 reference

PubMed ID

22587748

26 August 2017

Joshua M Hare

series ordinal

3

1 reference

26 August 2017

9 November 2011

1 reference

26 August 2017

Congestive Heart Failure

1 reference

26 August 2017

18

1 reference

26 August 2017

179-182

1 reference

26 August 2017

3

1 reference

Uric acid predicts clinical outcomes in heart failure: insights regarding the role of xanthine oxidase and uric acid in disease pathophysiology

26 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00262.X

Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00262.X

Two independent mutational events in the loss of urate oxidase during hominoid evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00262.X

Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00262.X

Prognostic usefulness of serum uric acid after acute myocardial infarction (the Japanese Acute Coronary Syndrome Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00262.X

Oxypurinol improves coronary and peripheral endothelial function in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00262.X

Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00262.X

Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00262.X

Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00262.X

Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00262.X

Serum level of uric acid, partly secreted from the failing heart, is a prognostic marker in patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00262.X

Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00262.X

Serum uric acid and the risk for hypertension and Type 2 diabetes in Japanese men: The Osaka Health Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00262.X

Hyperinsulinemia for the development of hypertension: data from the Hawaii-Los Angeles-Hiroshima Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00262.X

Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00262.X

The association between serum uric acid level and long-term incidence of hypertension: Population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00262.X

Hyperuricemia in childhood primary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00262.X

Serum uric acid in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00262.X

The Seattle Heart Failure Model: prediction of survival in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00262.X

Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00262.X

Nitroso-redox interactions in the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00262.X

Chronic treatment with allopurinol boosts survival and cardiac contractility in murine postischemic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00262.X

Xanthine oxidase inhibition ameliorates cardiovascular dysfunction in dogs with pacing-induced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00262.X

Xanthine oxidoreductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00262.X

Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00262.X

Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00262.X

Allopurinol improves endothelial dysfunction in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00262.X

Hyperuricemia induces endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00262.X

High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00262.X

Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00262.X

Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00262.X

Hyperuricaemia predicts poor outcome in patients with mild to moderate chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00262.X

Hyperuricaemia in patients with right or left heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2011.00262.X

10.1111/J.1751-7133.2011.00262.X

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22587748